Page last updated: 2024-08-24

goralatide and rxpa380

goralatide has been researched along with rxpa380 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beau, F; Cotton, J; Czarny, B; Dive, V; Georgiadis, D; Yiotakis, A1

Other Studies

1 other study(ies) available for goralatide and rxpa380

ArticleYear
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Circulation research, 2003, Jul-25, Volume: 93, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Substrate Specificity

2003